BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10419450)

  • 1. LEKTI, a novel 15-domain type of human serine proteinase inhibitor.
    Mägert HJ; Ständker L; Kreutzmann P; Zucht HD; Reinecke M; Sommerhoff CP; Fritz H; Forssmann WG
    J Biol Chem; 1999 Jul; 274(31):21499-502. PubMed ID: 10419450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance.
    Mägert HJ; Kreutzmann P; Ständker L; Walden M; Drögemüller K; Forssmann WG
    Int J Biochem Cell Biol; 2002 Jun; 34(6):573-6. PubMed ID: 11943586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI.
    Lauber T; Schulz A; Schweimer K; Adermann K; Marx UC
    J Mol Biol; 2003 Apr; 328(1):205-19. PubMed ID: 12684009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LEKTI domain 15 is a functional Kazal-type proteinase inhibitor.
    Vitzithum K; Lauber T; Kreutzmann P; Schulz A; Sommerhoff CP; Rösch P; Marx UC
    Protein Expr Purif; 2008 Jan; 57(1):45-56. PubMed ID: 17936012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant production, purification and biochemical characterization of domain 6 of LEKTI: a temporary Kazal-type-related serine proteinase inhibitor.
    Kreutzmann P; Schulz A; Ständker L; Forssmann WG; Mägert HJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(1):75-81. PubMed ID: 15026000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate disulfide formation in Escherichia coli: overexpression and characterization of the first domain (HF6478) of the multiple Kazal-type inhibitor LEKTI.
    Lauber T; Marx UC; Schulz A; Kreutzmann P; Rösch P; Hoffmann S
    Protein Expr Purif; 2001 Jun; 22(1):108-12. PubMed ID: 11388807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and expression of a novel Kazal-type serine proteinase inhibitor gene from Zhikong scallop Chlamys farreri, and the inhibitory activity of its recombinant domain.
    Wang B; Zhao J; Song L; Zhang H; Wang L; Li C; Zheng P; Zhu L; Qiu L; Xing K
    Fish Shellfish Immunol; 2008 May; 24(5):629-37. PubMed ID: 18353679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical features, molecular biology and clinical relevance of the human 15-domain serine proteinase inhibitor LEKTI.
    Walden M; Kreutzmann P; Drögemüller K; John H; Forssmann WG; Hans-Jürgen M
    Biol Chem; 2002; 383(7-8):1139-41. PubMed ID: 12437098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
    Mitsudo K; Jayakumar A; Henderson Y; Frederick MJ; Kang Y; Wang M; El-Naggar AK; Clayman GL
    Biochemistry; 2003 Apr; 42(13):3874-81. PubMed ID: 12667078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A.
    Jayakumar A; Kang Y; Mitsudo K; Henderson Y; Frederick MJ; Wang M; El-Naggar AK; Marx UC; Briggs K; Clayman GL
    Protein Expr Purif; 2004 May; 35(1):93-101. PubMed ID: 15039071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant expression and characterization of five-domain Kazal-type serine proteinase inhibitor of black tiger shrimp (Penaeus monodon).
    Jarasrassamee B; Supungul P; Panyim S; Klinbunga S; Rimphanichayakit V; Tassanakajon A
    Mar Biotechnol (NY); 2005; 7(1):46-52. PubMed ID: 15756478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role.
    Mägert HJ; Kreutzmann P; Drögemüller K; Ständker L; Adermann K; Walden M; John H; Korting HC; Forssmann WG
    Eur J Med Res; 2002 Feb; 7(2):49-56. PubMed ID: 11891144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization, expression and function analysis of a five-domain Kazal-type serine proteinase inhibitor from pearl oyster Pinctada fucata.
    Zhang D; Ma J; Jiang S
    Fish Shellfish Immunol; 2014 Mar; 37(1):115-21. PubMed ID: 24378679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization, kinetics, and possible function of Kazal-type proteinase inhibitors of Chinese white shrimp, Fenneropenaeus chinensis.
    Wang ZH; Zhao XF; Wang JX
    Fish Shellfish Immunol; 2009 Jun; 26(6):885-97. PubMed ID: 19379816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The full-length cDNA of anticoagulant protein infestin revealed a novel releasable Kazal domain, a neutrophil elastase inhibitor lacking anticoagulant activity.
    Lovato DV; Nicolau de Campos IT; Amino R; Tanaka AS
    Biochimie; 2006 Jun; 88(6):673-81. PubMed ID: 16469426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning, sequencing and expression of a serine proteinase inhibitor gene from Toxoplasma gondii.
    Pszenny V; Angel SO; Duschak VG; Paulino M; Ledesma B; Yabo MI; Guarnera E; Ruiz AM; Bontempi EJ
    Mol Biochem Parasitol; 2000 Apr; 107(2):241-9. PubMed ID: 10779600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary DNA cloning and kinetic characterization of a novel intracellular serine proteinase inhibitor: mechanism of action with trypsin and factor Xa as model proteinases.
    Morgenstern KA; Sprecher C; Holth L; Foster D; Grant FJ; Ching A; Kisiel W
    Biochemistry; 1994 Mar; 33(11):3432-41. PubMed ID: 8136380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel Kazal-type serine proteinase inhibitor of Arabidopsis thaliana.
    Pariani S; Contreras M; Rossi FR; Sander V; Corigliano MG; Simón F; Busi MV; Gomez-Casati DF; Pieckenstain FL; Duschak VG; Clemente M
    Biochimie; 2016 Apr; 123():85-94. PubMed ID: 26853817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI).
    Schechter NM; Choi EJ; Wang ZM; Hanakawa Y; Stanley JR; Kang Y; Clayman GL; Jayakumar A
    Biol Chem; 2005 Nov; 386(11):1173-84. PubMed ID: 16307483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor.
    Meyer-Hoffert U; Wu Z; Schröder JM
    PLoS One; 2009; 4(2):e4372. PubMed ID: 19190773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.